Document:

Prepared by R.R. Donnelley Financial -- Warrant to purchase Series D convertible preferred shares

 Exhibit 4.03 
  
 THE WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS, OR THE ISRAELI SECURITIES LAW 1968. NEITHER THE WARRANTS NOR SUCH SHARES MAY BE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION
THEREFROM. 
  
 VOID AFTER 5:00 P.M., ISRAELI TIME, ON FEBRUARY 8,
2005, OR IF NOT A BUSINESS DAY, AS DEFINED HEREIN, AT 5:00 P.M., ISRAELI TIME, ON THE NEXT FOLLOWING BUSINESS DAY. 
  
 DEALTIME.COM LTD. 
  
 WARRANT TO PURCHASE 
 227,077 
 SERIES D CONVERTIBLE PREFERRED SHARES 
  
 DEALTIME.COM LTD., a company organized under the laws of the State of Israel (the “Company”), hereby grants to Warburg Dillon Read LLC
(the “Warrantholder”), the right to purchase from the Company, subject to the terms and conditions hereof, at any time on or after 9:00 A.M., Israeli time, on the Initial Exercise Date, and before 5:00 P.M., Israeli time, on the
Expiration Date (or, if such day is not a Business Day, at or before 5:00 P.M., Israeli time, on the next following Business Day), 227,077 duly authorized, validly issued, fully paid and non-assessable Series D Preferred Shares (as defined herein)
of the Company at the Exercise Price (as defined herein). This Warrant is granted in connection with the transactions described in that certain Subscription Agreement between the Company and the Purchasers described therein, dated as of February 8,
2000 (the “Subscription Agreement”). The number of shares purchasable hereunder and the Exercise Price are each subject to adjustment from time to time provided in Article III hereof. Upon the exercise of the Warrants or any
part thereof, the Warrantholder shall execute and become a party to the Amended and Restated Shareholders Rights Agreement dated of even date herewith or any agreement then in effect between the Company’s shareholders that provides for the
granting of registration rights to such shareholders (the “SRA”). Upon the issuance of Warrant Shares, the holders of the Warrant Shares shall be entitled to such rights and privileges (including registration rights) and shall be
bound by such obligations as set forth in the SRA, all with respect to the exercised Warrant Shares. 
  

 ARTICLE I 
  
 Section 1.01: Definition of Terms. As used in this Warrant, the following capitalized terms shall have the following respective meanings:

  
 Affiliate: With respect to any Person, any other Person
that, (i) directly or through one or more intermediaries, controls such Person or (ii) is controlled by or is under common control with such Person. 
  
 Business Day: A day other than a Saturday, Sunday or other day on which banks in Israel are authorized by law to remain closed. 
  
 Control: With respect to any Person, possession directly or
indirectly, of the power to direct or cause the direction of the management policies of such Person, whether through the ownership of voting securities, by contract or otherwise. 
  
 Conversion Shares: Ordinary Shares issuable upon conversion of the Series D Preferred Shares. 
  
 Dollars and the sign “$”: The lawful currency of the United
States of America. 
  
 Exercise Price: $5.78 per Warrant
Share as such price may be adjusted from time to time pursuant to Article III hereof 
  
 Expiration Date: 5:00__, Israeli time, on February 8, 2005, or, if such day is not a Business Day, the next succeeding day which is a Business Day. 
  
 Initial Issue Date: February 8, 2000.  
  
 Initial Exercise Date: February 8, 2001. 
  
 NASD: National Association of Securities Dealers, Inc. and NASDAQ: NASD Automated Quotation System.

  
 NIS: New Israeli Shekels. 
  
 Ordinary Shares: Ordinary Shares, nominal value NIS 0.01 per share, of
the Company. 
  
 Person: An individual, partnership, joint
venture, corporation, limited liability company, trust, unincorporated organization, government or any department or agency thereof or any other entity engaging in commercial activities. 
  
 Public Offering: A public offering of the Company’s equity securities pursuant to an effective registration
statement under the Securities Act or equivalent law of another jurisdiction. 
  

 2 

 Registration Statement: Any Registration Statement of the Company filed or to be filed with the
SEC which covers the Warrant Shares, including all amendments (including post-effective amendments) and supplements thereto, all exhibits thereto and all material incorporated therein by reference. 
  
 SEC: The Securities and Exchange Commission or any other federal
agency at the time administering the Securities Act. 
  
 Securities Act: The Securities Act of 1933, as amended. 
  
 Series D Preferred Shares: Series D Convertible Preferred Shares, nominal value NIS 0.01 per share, of the Company. 
  
 Series D Preferred Share Equivalents: Securities that are convertible into or exercisable or exchangeable for Series D Preferred Shares.

  
 Senior Officer: Any of the Chief Executive Officer, the
Chief Financial Officer, or the Chief Operating Officer of the Company, or any person performing substantially similar duties. 
  
 Subscription Form: The form annexed hereto which must be surrendered upon exercise of this Warrant. 
  
 Warrants: This Warrant and all other warrants that may be issued in
its or their place. 
  
 Warrantholder: The Person to whom
this Warrant is initially issued, or any successor in interest thereto, or any permitted assignee or transferee thereof, in whose name this Warrant or any portion thereof is registered upon the books to be maintained by the Company for that purpose.

  
 Warrant Shares: Series D Preferred Shares, Series D
Preferred Share Equivalents and other securities purchased or purchasable upon exercise of the Warrants. 
  
 ARTICLE II 
  
 DURATION AND EXERCISE OF WARRANT 
  
 Section 2.01:
Duration of Warrant. The Warrantholder may exercise this Warrant, in whole or in part, at any time and from time to time after 9:00 A.M., Israeli time, on the Initial Exercise Date, and before 5:00 P.M., Israeli time, on the Expiration Date. If
this Warrant is not exercised on or before the Expiration Date, it shall become void, and all rights hereunder shall thereupon cease. The Warrant shall automatically be exercised pursuant to Section 2.03 hereof immediately before its expiration
pursuant to this Section unless the Warrantholder notifies the Company in writing to the contrary before such termination. 
  

 3 

 Section 2.02: Cash Exercise of Warrant. 
  
 (a) The Warrantholder may exercise this Warrant, in whole or in part by
presentation and surrender of this Warrant to the Company at its principal corporate office or at the office of its share transfer agent, if any, with the Subscription Form annexed hereto duly executed and accompanied by payment of the Exercise
Price for each Warrant Share to be purchased. The Exercise Price shall be paid by certified check or by a wire transfer made pursuant to instructions from the Company or a bank or certified check payable to the Company in an amount equal to the
Exercise Price multiplied by the number of Warrant Shares being purchased upon such exercise. 
  
 (b) In case the Warrantholder shall exercise this Warrant with respect to less than all of the Warrant Shares that may be purchased under this Warrant, the Company shall execute a new warrant in the form of this
Warrant for the balance of such Warrant Shares and deliver such new Warrant to the Warrantholder. 
  
 Section 2.03: Net Exercise of Warrant. 
  
 (a) In lieu of the payment method set forth in Section 2.02 above, the Warrantholder may elect to exchange this Warrant for a number of Warrant Shares
equal in value to the increase in value of the Warrant Shares otherwise Purchasable hereunder on the date of exchange. If the Warrantholder elects to exchange this Warrant as provided in this Section 2.03, the Warrantholder shall tender to the
Company this Warrant along with the Subscription Form, and the Company shall issue to the Warrantholder the number of Warrant Shares computed using the following formula: 
  

	
	 X=Y(A-B) 

	          A

	
	 Where:

	
	 X = the number of Warrant Shares to be issued to the Warrantholder.

	
	 Y = the number of Warrant Shares purchasable under this Warrant (as adjusted to the date of such calculation).

	
	 A = the Fair Market Value (as defined below) of one Warrant Share.

	
	 B = Exercise Price (as adjusted to the date of such calculation).

  
 (b) For purposes
hereof, the “Fair Market Value” of a Warrant Share shall be determined by the Company’s Board of Directors in good faith; provided, however, that where there exists a public market for the Company’s Ordinary
Shares at the time of such exercise, the fair market value of the Warrant Shares per share shall be the aggregate value of the number of 

  

 4 

 
Ordinary Shares into which one Warrant Share is convertible (as adjusted) based on the fair market value per Ordinary Share determined as follows:

  

	 	(i)	If the Company’s Ordinary Shares are listed on a national securities exchange or quoted on the National Association of Securities Dealers, Inc. Automated Quotation/National
Market System (NASDAQ/NMS) or other securities quotation system, then the closing or last sale price, respectively, reported for the exercise date. 

  

	 	(ii)	If the Company’s Ordinary Shares are not listed on a national securities exchange or quoted on NASDAQ/NMS or other securities quotation system, but are traded in the
over-the-counter market, then the mean of the closing bid and asked prices as reported in the Over-The-Counter Market Summary. 

  

	 	(iii)	If the Warrant is exercised in connection with a Public Offering (or within five trading days after the pricing of the Public Offering), then the per share offering price (before
deduction of discounts, commissions, or expenses) in such Public Offering. 

  
 (c) In the event of a net exercise pursuant to this Section 2.03, the Warrant must be exercised in whole and must be surrendered, _________ new Warrant shall be issued. 
  
 (d) If all outstanding series D Preferred Shares have been converted into
Ordinary Shares pursuant to the Articles of Association of the Company, the Warrant shall convert into a Warrant to purchase Ordinary Shares. 
  
 Section 2.04: Share Certificates, Taxes, Filings, Etc. 
  
 (a) In the event of any exercise of the rights represented by this Warrant, the Company shall within five Business Days cause to be issued certificates
for the total number of Warrant Shares for which this Warrant is being exercised (adjusted to reflect the effect of the anti-dilution provisions contained in Article III hereof, if any) in such denominations as are requested for delivery to the
Warrantholder, and the Company shall thereupon deliver such certificates to the Warrantholder. The Warrantholder shall be deemed to be the holder of record of the Warrant Shares issuable upon such exercise, notwithstanding that the share transfer
books of the Company shall then be closed or that certificates representing such Warrant Shares shall not then be actually delivered to the Warrantholder. If at the time this Warrant is exercised, a Registration Statement is not in effect to
register under the Securities Act the resale of the Warrant Shares issuable upon exercise of this Warrant, the Company may require the Warrantholder to make such representations, and may place such legends on certificates representing such Warrant
Shares, as may be reasonably required in the opinion of counsel to the Company to permit such Warrant Shares to be issued without such registration. 
  

 5 

 (b) The Company shall pay any and all stamp-tax and similar taxes which may be payable in respect of the
issue of any Warrant Shares to the Warrantholder of the Warrant being exercised. 
  
 (c) The Company shall assist and cooperate with any Warrantholder required to make any governmental filings or obtain any governmental approvals prior to or in connection with any exercise of this Warrant (including,
without limitation, making any filings required to be made by the Company). 
  
 (d) Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection with a Public Offering, the exercise of any portion of this Warrant may, at the election of the
holder hereof, be conditioned upon the consummation of the Public Offering in which case such exercise shall not be deemed to be effective until the consummation of the Public Offering. 
  
 (e) The Company shall take all such actions as may reasonably be necessary to assure that all Warrant Shares may be issued
without violation of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which the Warrant Shares may be listed (except for official notice of issuance which shall be immediately delivered by
the Company upon each such issuance). 
  
 Section 2.05:
Reservation of Shares. The Company hereby agrees that at all times there shall be reserved for issuance and delivery upon exercise of this Warrant such number of Series D Preferred Shares or other capital share of the Company that from time to
time would be issuable upon exercise of this Warrant and such number of Conversion Shares as may be issuable upon conversion of all of such Series D Preferred Shares. All such shares shall be duly authorized, and when issued upon such exercise,
shall be validly issued, fully paid and nonassessable, free and clear of all liens, security interests, charges and other encumbrances and, except as may be required by applicable securities law, restrictions on sale, and free and clear of all
preemptive rights. Upon each adjustment in the number of Warrant Shares for which Warrants are exercisable pursuant to Article III hereof, the Company shall reserve an additional number of Warrant Shares sufficient to permit the exercise of all
Warrants as so adjusted. 
  
 Section 2.06: Listing. Prior
to the issuance of any Series D Preferred Shares upon exercise of this Warrant, the Company shall use all reasonable efforts to secure the listing of such Conversion Shares as may be issuable upon conversion of the Series D Preferred Shares upon
each national securities exchange or automated quotation system, if any, upon which shares of Conversion Shares are then listed (subject to official notice of issuance upon exercise of this Warrant) and shall maintain, so long as any other Ordinary
Shares shall be so listed, such listing of all Conversion Shares from time to time issuable upon the conversion of the Series D Preferred Shares; and the Company shall use all reasonable efforts to so list on each national securities exchange or
automated quotation system, and shall maintain such listing of, any other capital shares of the Company issuable upon the exercise of this Warrant if and so long as any shares of the same class shall be listed on such national securities exchange or
automated quotation system. 
  

 6 

 Section 2.07: Fractional Interests. The Company shall not be required to issue fractional shares
of Warrant Shares on the exercise of Warrants. If more than one Warrant shall be presented for exercise in full at the same time by the same Warrantholder, the number of full shares of Warrant Shares which shall be issuable upon the exercise thereof
shall be computed on the basis of the aggregate number of shares of Warrant Shares purchasable on exercise of the Warrants so presented. If any fraction of a share of Warrant Shares would, except for the provisions of this Section 2.07, be issuable
on the exercise of any Warrants (or specified portion thereof), the Company shall pay to the Warrantholder an amount in cash equal to the product of (i) such fraction of a share of Warrant Shares and (ii) the difference between the Fair Market Value
of a share of Warrant Shares and the Exercise Price. 
  
 ARTICLE
III 
  
 ADJUSTMENT OF SERIES D PREFERRED SHARES 
 PURCHASABLE AND OF EXERCISE PRICE 
  
 The Exercise Price and the number and kind of Warrant Shares shall be subject to adjustment from time to time upon the happening of certain events as
provided in this Article III. 
  
 Section 3.01: Mechanical
Adjustments. 
  
 (a) If at any time or from time to time after
the date hereof the Company shall (i) declare a dividend or make a distribution on the Series D Preferred Shares in each case payable in shares of its share capital (whether Series D Preferred Shares or of share capital of any other class), (ii)
subdivide, reclassify or recapitalize its outstanding Series D Preferred Shares into a greater number of shares, (iii) combine, reclassify or recapitalize its outstanding Series D Preferred Shares into a smaller number of shares, or (iv) issue any
shares of its share capital by reclassification of its Series D Preferred Shares (including any such reclassification in connection with a consolidation or a merger in which the Company is the surviving corporation), the Exercise Price in effect at
the time of the record date of such dividend, distribution, subdivision, combination, reclassification or recapitalization shall be adjusted so that the Warrantholder shall be entitled to receive upon exercise of this Warrant the aggregate number
and kind of shares which, if this Warrant had been exercised in full immediately prior to such event, such Warrantholder would have owned upon such exercise and been entitled to receive by virtue of such dividend, distribution, subdivision,
combination, reclassification or recapitalization. Any adjustment required by this Section 3.01(a) shall be made immediately after the record date, in the case of a dividend or distribution, or the effective date, in the case of a subdivision,
combination, reclassification or recapitalization, to allow the purchase of such aggregate number and kind of shares. 
  
 (b) If at any time or from time to time after the date hereof the Company shall fix a record date for the issuance or making a distribution to all holders
of the Series D Preferred Shares (including any such distribution to be made in connection with a consolidation or merger in which the Company is to be the surviving corporation) of evidences of its indebtedness, any other securities of the Company
or any cash, property or other assets (excluding a combination, reclassification or recapitalization referred to in Section 3.01(a) hereof, cash dividends or cash 

  

 7 

 
distributions paid out of net profits or earned surplus legally available therefor and in the ordinary course of business or subscription rights, options or
warrants for Series D Preferred Shares or Series D Preferred Shares Equivalents (any such non-excluded event being herein called a “Special Dividend”)), the Warrantholder shall be entitled upon exercise of this Warrant for the
purchase of any or all of the Warrant Shares subject hereto, to receive the amount of such assets which would have been payable to the Warrantholder had such Warrantholder been the holder of such Warrant Shares on the record date for the
determination of such shareholders entitled to receive the Special Dividend. 
  
 (c) If at any time or from time to time after the date hereof the Company shall make a distribution to all holders of the Series D Preferred Shares of stock of a subsidiary or securities convertible into or
exercisable for such stock, then in lieu of an adjustment in the Exercise Price or the number of Warrant Shares purchasable upon the exercise of this Warrant, each Warrantholder, upon the exercise hereof at any time after such distribution, shall be
entitled to receive from the Company, such subsidiary or both, as the Company shall determine, the stock or other securities to which such Warrantholder would have been entitled if such Warrantholder had exercised this Warrant immediately prior to
such distribution, all subject to further adjustment as provided in this Article III, and the Company shall reserve, during the term of the Warrant, such securities of such subsidiary or other corporation; provided, however, that no
adjustment in respect of dividends or interest on such stock or other securities shall be made during the term of this Warrant or upon its exercise 
  
 (d) Whenever the Exercise Price payable upon exercise of each Warrant is adjusted pursuant to paragraph (a) of this Section 3.01, the number of Warrant
Shares shall simultaneously be adjusted by multiplying the number of Warrant Shares initially issuable upon exercise of each Warrant by the Exercise Price in effect immediately prior to the date thereof and dividing the product so obtained by the
Exercise Price, as adjusted. 
  
 (e) No adjustment in the Exercise
Price shall be required unless such adjustment would require an increase or decrease of at least five cents ($.05) in such price; provided, however, that any adjustments which by reason of this paragraph (e) are not required to be made shall
be carried forward and taken into account in any subsequent adjustment. All calculations under this Section 3.01 shall be made to the nearest cent or to the nearest one-hundredth of a share, as the case may be. Notwithstanding anything in this
Section 3.01 to the contrary, the Exercise Price shall not be reduced to less than the then existing par value of the Series D Preferred Shares as a result of any adjustment made hereunder. 
  
 (f) In the event that at any time, as a result of any adjustment made
pursuant to Section 3.01(a) hereof, the Warrantholder thereafter shall become entitled to receive any shares of share capital of the Company other than Series D Preferred Shares, thereafter the number of such other shares so receivable upon exercise
of any Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Series D Preferred Shares contained in Section 3.01 hereof. 
  

 8 

 (g) In the event that the Company shall enter into any transaction for the purpose of avoiding the
application of the provisions of Article III hereof, the benefits provided by such provisions shall nevertheless apply and be preserved. 
  
 Section 3.02: Notices of Adjustment. Whenever the number of Warrant Shares or the Exercise Price is adjusted as herein provided, the Company shall
prepare and deliver forthwith to the Warrantholder a certificate signed by a Senior Officer setting forth the adjusted number of Series D Preferred Shares purchasable upon the exercise of this Warrant and the Exercise Price for such shares after
such adjustment, setting forth a brief statement of the facts requiring such adjustment and setting forth the computation by which such adjustment was made. 
  
 Section 3.03: No Adjustment for Dividends. Except as provided in Section 3.01 hereof, no adjustment in respect of any cash dividends shall be made
during the term of this Warrant or upon the exercise of this Warrant. 
  
 Section 3.04: Preservation of Purchase Rights - Adjustment for Reclassification; Exchange and Substitution. If the Warrant Shares issuable upon the exercise of Warrant shall be changed into the same or any different number of shares
of any class or any series of any class of share capital, whether by capital reorganization, reclassification or otherwise (other than a subdivision or combination of shares or a share dividend provided for above, or a reorganization, merger,
consolidation or sale of assets provided or in Section 3.05)), then, and in each such event, the Warrantholder shall have the right thereafter to convert such Warrant Shares into the kind and amount of shares and other securities property receivable
upon such reorganization, reclassification or other change, all subject to further adjustment as provided for in this Section 3. 
  
 Section 3.05. Reorganizations, Mergers, Consolidations or Sales of Assets. If, at any time or from time to time, there shall be a merger or
consolidation of the Company with or into another Company, or the sale of all or substantially all of the Company’s properties and assets to any other person, then, as a part of such reorganization, merger, consolidation or sale, the Warrant
shall expire and terminate on the date of such reorganization, merger, consolidation or sale, provided that the Warrantholder shall have received a minimum of thirty (30) days written notice prior to the date of such reorganization, merger,
consolidation or sale. In the event the transaction referred to in this Section 3.05 is not consummated, but rather is terminated, canceled or is not consummated, the rights granted hereunder shall thereafter be treated as if that agreement had
never been entered into. In such event, the provisions of this Section 3.05 shall similarly apply to successive reclassifications, capital reorganizations, consolidations or mergers. 
  
 Section 3.06: Form of Warrant After Adjustments. The form of this Warrant need not be changed as a result of any
adjustments in the Exercise Price or the number or kind of the Warrant Shares, and Warrants theretofore or thereafter issued may continue to express the same price and number and kind of shares as are stated in this Warrant, as initially issued.

  
 Section 3.07: Treatment of Warrantholder. Prior to due
presentment for registration of transfer of this Warrant, the Company may deem and treat the Warrantholder as 

  

 9 

 
the absolute owner of this Warrant (notwithstanding any notation of ownership or other writing hereon) for all purposes and shall not be affected by any
notice to the contrary. 
  
 ARTICLE IV 
  
 OTHER PROVISIONS RELATING TO RIGHTS OF WARRANTHOLDER 
  
 Section 4.01: No Rights as Shareholders: Notice to Warrantholders.
Nothing contained in this Warrant shall be construed as conferring upon the Warrantholder or his, her or its transferee, the right to vote or to receive dividends or to consent or to receive notice as a shareholder in respect of any meeting of
shareholders for the election of directors of the Company or of any other matter, or any rights whatsoever as shareholders of the Company. The Company shall give notice to the Warrantholder by certified mail, overnight courier service or personal
delivery if at any time prior to the expiration or exercise in full of the Warrants, any of the following events shall occur: 
  
 (a) the Company shall authorize the payment of any dividend payable in any securities on the Series D Preferred Shares or authorize the making of any
distribution (other than a cash dividend or cash distribution paid out of net profits or earned surplus legally available therefor) on the Series D Preferred Shares; 
  
 (b) the Company shall authorize the issuance to the holders of Series D Preferred Shares of any additional Series D
Preferred Shares or Series D Preferred Share Equivalents or of rights, options or warrants to subscribe for or purchase Series D Preferred Shares or Series D Preferred Share Equivalents or of any other subscription rights, options or warrants;

  
 (c) a dissolution, liquidation or winding up of the Company
shall be proposed by the Company’s board of directors; or 
  
 (d) a capital reorganization or reclassification of the Series D Preferred Shares (other than a subdivision or combination of the outstanding Series D Preferred Shares or a change in the par value of the Series D Preferred Shares) or any
consolidation or merger of the Company with or into another corporation (other than a consolidation or merger in which the Company is the surviving corporation and that does not result in any reclassification or change of Series D Preferred Shares
outstanding) or in the case of any sale, lease, transfer, exchange, conveyance or other disposition to another corporation of all or substantially all of the assets of the Company in a single transaction or series of related transactions.

  
 Such giving of notice shall be initiated at least ten Business
Days prior to the date fixed as a record date or effective date or the date of closing of the Company’s share transfer books for the determination of the shareholders entitled to such dividend, distribution or subscription rights, or for the
determination of the shareholders entitled to vote on such proposed merger, consolidation, sale, conveyance, dissolution, liquidation or winding up. Such notice shall specify such record date or effective date or the date of closing the share
transfer books, as the case may be. Failure to provide such notice shall not affect the validity of any action taken in 

  

 10 

 
connection with such dividend, distribution or subscription rights, or proposed merger, consolidation, sale, conveyance, dissolution, liquidation or winding
up. 
  
 Section 4.02: Lost, Stolen, Mutilated or Destroyed
Warrants. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may in its discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as, and in substitution for, this Warrant. 
  
 ARTICLE V 
  
 OTHER MATTERS

  
 Section 5.01: Successors and Assigns. All the covenants
and provisions of this Warrant by or for the benefit of the Company shall bind and inure to the benefit of its successors and permitted assigns hereunder. 
  
 Section 5.02: Integration/Entire Agreement. This Warrant is intended by the parties as a final expression of their agreement and intended to be a
complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. This Warrant supersedes all prior agreements and understandings between the parties with respect
to such subject matters. 
  
 Section 5.03: Amendments and
Waivers. The provisions of this Warrant may not be amended, modified or supplemented, and waiver or consents to departure from the provisions hereof may not be given unless the Company has obtained the written consent of Warrantholders of
outstanding Warrants exercisable for a majority of the unissued Warrant Shares. All Warrantholders shall be bound by any consent authorized by this Section 5.03. Notwithstanding anything contained herein to the contrary, the Warrantholder agrees to
be bound by any amendments and waivers agreed to pursuant to this Section 5.03. 
  
 Section 5.04: Counterparts. This Warrant may be executed in two or more counterparts each of which so executed shall be deemed to be an original and all of which taken together shall constitute one and the same
agreement. 
  
 Section 5.05: Governing Law. This Warrant
shall be governed by and construed in accordance with the internal laws of the State of New York. 
  
 Section 5.06: Severability. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstances,
is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provisions in every other respect and of the remaining provisions contained herein shall not be affected or impaired thereby. 
  
 Section 5.07: Computations of Consent. Whenever the consent or
approval of Warrantholders of a specified percentage is required hereunder, Warrants held by the Company 

  

 11 

 
or its Affiliates (other than the Warrantholders if they are deemed to be such Affiliates solely by reason of their holdings of such Warrants) shall not be
counted in determining whether such consent or approval was given by the Warrantholders of such required percentage. 
  
 Section 5.08 Transfer of Warrant. The Warrantholder, by its acceptance hereof, agrees that it will not, directly or indirectly, offer, transfer,
sell, pledge, hypothecate or otherwise dispose of this Warrant or any portion hereof (or solicit any offer to buy, purchase, or otherwise acquire or take a pledge of the Warrant or any portion hereof), except in compliance with the Securities Act,
the rules and regulations promulgated thereunder and applicable state securities laws and the delivery to the Company of a legal opinion with respect to such compliance. 
  
 Section 5.09: Notice. Any notices or certificates by the Company to the Warrantholder and by the Warrantholder to the
Company shall be deemed delivered if in writing and delivered in Person or by certified or registered mail (return receipt requested): (i) if to the Warrantholder, addressed to WDR, at 299 Park Avenue, New York, NY 10171, Attention: Legal
Department, with a copy at 555 California Street, Suite 4650, San Francisco, CA Attention: Bryan Rutberg, facsimile number (415) 352-5510, and (ii) if to the Company, to Dealtime.com Ltd, 475 Fifth Avenue, 2nd Floor, New York, NY 10017-6620,
Attention: Dan Ciporin, facsimile number (212) 905-8100. 
  
 The
Company may change its address by written notice to the Warrantholder and the Warrantholder may change its address by written notice to the Company. 
  

 12 

 IN WITNESS WHEREOF the Company, by an officer authorized to act on its behalf, has set its hand to this
Warrant effective as of the 8th day of February, 2000. 
  

			
	DEALTIME.COM LTD.
		
	By:	 	 /s/ Daniel J. Ciporin

	 	 	

	 	 	 Name: Daniel J. Ciporin
 Title:   President & CEOPrepared by R.R. Donnelley Financial -- 2003 Omnibus Stock Option and Restricted Stock Incentive Plan

  
 Exhibit 10.01

  
 

 
  
 SHOPPING.COM LTD.

  
 2003 OMNIBUS STOCK OPTION 
  
 AND RESTRICTED STOCK 
  
 INCENTIVE PLAN 
  

	1.	PURPOSE; TYPES OF AWARDS; CONSTRUCTION. 

  
 Purpose. The purpose of the Shopping.com Ltd. 2003 Omnibus Stock Option and Restricted Stock Incentive Plan (the “Plan”) is to afford an
incentive to employees, officers, directors and consultants of Shopping.com Ltd. (the “Company”), or any subsidiary of the Company which now exists or hereafter is organized or acquired by the Company, to acquire a proprietary interest in
the Company, to continue as employees, officers, directors or consultants, to increase their efforts on behalf of the Company and to promote the success of the Company’s business. This Plan amends and replaces the DealTime Ltd. 1999 Omnibus
Stock Option and Restricted Stock Incentive Plan (the “1999 Plan”). The effective date of this Plan is January 1, 2003. 
  
 Types of Awards. The Plan is intended to enable the Company to issue Awards under varying tax regimes, including without limitation (i) pursuant and
subject to the “capital track” provisions of Section 102 (“Section 102”) of the Israeli Income Tax Ordinance (New Version) 1961, as in effect on January 1, 2003 (the “Ordinance”) and any regulations, rules, orders or
procedures promulgated thereunder; (“102 Stock Options”) (ii) pursuant to Section 3(9) of the Ordinance (“3(9) Stock Options”); (iii) as “incentive stock options” (“Incentive Stock Options”) within the meaning
of Section 422 of the United States Internal Revenue Code of 1986, as amended (the “Code”); (iv) Nonqualified Stock Options (as defined below) (all 102 Stock Options, 3(9) Stock Options, Incentive Stock Options and Nonqualified Stock
Options, as well as options issued under other tax regimes collectively, the “Options”); and (v) restricted Shares (“Restricted Stock”) under the Plan. Apart from issuance under the relevant tax regimes of the State of Israel and
the United States of America, the Plan contemplates issuances to Grantees (as defined below) in other jurisdictions with respect to which the Committee (as defined below) is empowered make the requisite adjustments in the Plan and set forth the
relevant conditions in the Company’s agreement with the Grantees in order to comply with the requirements of the tax regimes in said jurisdictions. 
  
 The Plan contemplates the issuance of Awards by the Company, both as a private company and, to the extent applicable, as a publicly traded company.

  
 Construction. To the extent any provision herein conflicts
with the conditions of any relevant tax law or regulation which are relied upon for tax relief in respect of a particular Option or Share granted to a Grantee, the provisions of said law or 

  

 
regulation shall prevail over those of the Plan, and the Committee (as defined below) is empowered hereunder to interpret and enforce the said prevailing
provisions. 
  

	2.	DEFINITIONS. 

  
 As used in this Plan, the following words and phrases shall have the meanings indicated: 
  

	 	2.1.	“Awards” shall mean grants of Options, Shares or Restricted Stock 

  

	 	2.2.	“Board” shall mean the Board of Directors of the Company. 

  

	 	2.3.	“Committee” shall mean a committee established by the Board to administer the Plan. 

  

	 	2.4.	“Companies Law” shall mean the Israel Companies Law – 1999, as amended. 

  

	 	2.5.	“Disability” shall mean, unless otherwise specified in the Option Agreement, a Grantee’s inability to perform his duties with the Company or any of its affiliates by
reason of any medically determinable physical or mental impairment, as determined by a physician selected by the Grantee and acceptable to the Company. 

  

	 	2.6.	“Exercise Period” shall mean the period in which the Option shall be exercisable. 

  

	 	2.7.	“Exercise Price” shall mean the exercise price for each Ordinary Share covered by an Option. 

  

	 	2.8.	“Fair Market Value” per share as of a particular date shall mean (i) the closing sales price per Share on the securities exchange on which the Shares are principally
traded on the day immediately preceding such date or if there was no trading of Shares on such date, the closing sales price per Share on such securities exchange as of the last day on which there was a sale of such Shares on such exchange; or (ii)
if the Shares are listed on the Nasdaq National Market, the last reported price per Share on the Nasdaq National Market on the trading day immediately preceding such day; or (iii) if the Shares are then traded in an over-the-counter market, the
average of the closing bid and asked prices for the Shares in such over-the-counter market on the trading day immediately preceding such day; or (iv) if the Shares are not then listed on a securities exchange or market or traded in an
over-the-counter market, such value as the Committee, in its sole discretion, shall determine, which determination shall be conclusive and binding on all persons. 

  

	 	2.9.	“Grantee” shall mean a person who receives a grant of Options, Restricted Stock or Shares or other Awards under the Plan, who at the time of grant is an employee, officer,
director or consultant of the Company. 

  

	 	2.10.	“Initial Public Offering” shall mean the underwritten initial public offering of Shares. 

  

	 	2.11.	“Nonqualified Stock Option” shall mean any Option not designated as an Incentive Stock Option, 102 Stock Option or 3(9) Stock Option. 

  

	 	2.12.	 “Parent” shall mean any company (other than the Company) in an unbroken chain of companies ending with the Company if, at the time of granting an 

  

 - 2 - 

	 	 
Award, each of the companies other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of
stock in one of the other companies in such chain. 

  

	 	2.13.	“Retirement” shall mean a Grantee’s retirement pursuant to applicable law or in accordance with the terms of any tax-qualified retirement plan maintained by the
Company or any of its affiliates in which the Grantee participates. 

  

	 	2.14.	“Shares” shall mean the Ordinary Shares of the Company, each bearing a nominal value of NIS 0.01 or, at the discretion of the Committee or the Board and if expressly
specified in a grant of Options hereunder, shares of the Company’s capital of any other class as may be in existence at the time of such grant. 

  

	 	2.15.	“Subsidiary” shall mean any company (other than the Company) in an unbroken chain of companies beginning with the Company if, at the time of granting an Award, each of the
companies other than the last company in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other companies in such chain. 

  

	 	2.16.	“Ten Percent Shareholder” shall mean a Grantee who, at the time an Incentive Stock Option (and also with respect to any grant of a Nonqualified Stock Option when intended
to be exempt from qualification pursuant to California Corporations Code Sec. 25102(o)) is granted, owns shares possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or
Subsidiary. 

  

	 	2.17.	“Trustee” shall mean the trustee appointed by the Committee or the Board, as the case may be, to hold the respective Options, Restricted Stock and/or Shares, if so
appointed. 

  

	3.	ADMINISTRATION. 

  
 The Plan shall be administered by the Committee. However, in the event that the Board does not create a committee to administer the Plan, the Plan shall
be administered by the Board in its entirety. In such event, all references herein to the Committee shall be construed as references to the Board. 
  
 The Committee shall have the authority in its discretion to administer the Plan and to exercise all the powers and authorities either specifically granted
to it under the Plan or necessary or advisable in the administration of the Plan, including, without limitation: 
  

	 	(i)	the authority to grant Awards; 

  

	 	(ii)	to determine which Options shall constitute 102 Stock Options, 3(9) Stock Options, Incentive Stock Options, Nonqualified Stock Options or otherwise; 

  

	 	(iii)	to determine the Exercise Price of the Shares covered by each Option; 

  

	 	(iv)	to determine the Grantees to whom, and the time or times at which Awards shall be granted; 

  

	 	(v)	to determine the number of Shares to be covered by each Award; 

  

	 	(vi)	to interpret the Plan; 

  

 - 3 - 

	 	(vii)	to prescribe, amend and rescind rules and regulations relating to the Plan; 

  

	 	(viii)	to determine the terms and provisions of the Option Agreements (as defined in Section 6 below) (which need not be identical), and to cancel or suspend Awards, as necessary;

  

	 	(ix)	and to make all other determinations deemed necessary or advisable for the administration of the Plan, including to adjust the terms of the Plan or any Agreement so as to reflect
(i) changes in applicable Israeli, U.S. or other laws and (ii) the laws of other jurisdictions within which the Company wishes to grant Awards. 

  

All decisions, determination and interpretations of the Committee shall be final and binding on all Grantees of any Awards under this Plan. No member
of the Committee shall be liable for any action taken or determination made in good faith with respect to the Plan or any Award granted hereunder. 
  

	4.	ELIGIBILITY. 

  
 Options, Restricted Stock and Shares may be granted to employees, officers, directors and consultants of the Company and any Subsidiary, provided,
however, that 102 Stock Options and Incentive Stock Options may be granted only to employees of the Company or a Subsidiary and who, in the case of 102 Stock Options are not “Controlling Parties” as defined in the Ordinance, and 3(9) may
not be issued to employees of the Company or a Subsidiary. A person who has been granted an Option, Restricted Stock or Share hereunder may be granted additional Options, Restricted Stock or Shares, if the Committee shall so determine. In
determining the persons to whom Awards shall be granted and the number of shares to be covered by each Award, the Committee shall take into account the duties of the respective persons, their present and potential contributions to the success of the
Company and such other factors as the Committee shall deem relevant in connection with accomplishing the purpose of the Plan. 
  

	5.	SHARES. 

  
 The cumulative maximum number of Shares reserved for the grant of Awards under the Plan and the 1999 Plan shall be 22,271,624 (twenty-two million, two hundred seventy-one thousand, six hundred and twenty-four). Such
Shares may, in whole or in part, be authorized but unissued Shares or Shares that shall have been or may be reacquired by the Company (to the extent permitted pursuant to the Companies Law) or by a trustee appointed by the Board. Any of such Shares
which may remain unsold and which are not subject to outstanding options at the termination of the Plan shall cease to be reserved for the purpose of the Plan, but until termination of the Plan, the Company shall at all times reserve a sufficient
number of Shares to meet the requirements of the Plan. 
  
 If any
outstanding Award under the Plan should, for any reason, expire, be canceled or be forfeited without having been exercised in full, the Shares allocable to the unexercised, canceled or terminated portion of such Award shall (unless the Plan shall
have been terminated) become available for subsequent grants of Awards under the Plan. 
  

 - 4 - 

	6.	TERMS AND CONDITIONS OF OPTIONS. 

  
 Each Option granted pursuant to the Plan shall be evidenced by a written agreement between the Company and the Grantee (the “Option Agreement”),
in such form and containing such terms and conditions as the Committee shall from time to time approve, which Option Agreement shall comply with and be subject to the following terms and conditions, unless otherwise specifically provided in such
Option Agreement. For purposes of interpreting this Section 6, a director’s service as a member of the Board shall be deemed to be employment with the Company provided, that for the purpose of Incentive Stock Options and 102 Stock Options, a
director of the Company or Subsidiary shall only be entitled to such Options in the event that there exists an employee-employer relationship between such director and the Company or Subsidiary. 
  

	 	6.1.	NUMBER OF SHARES. Each Option Agreement shall state the number of Shares to which the Option relates. 

  

	 	6.2.	TYPE OF OPTION. Each Option Agreement shall specifically state the type of Option granted thereunder and whether it constitutes a 102 Stock Option, 3(9) Stock Option, Incentive
Stock Option, Nonqualified Stock Option or otherwise. 

  

	 	6.3.	EXERCISE PRICE. Each Option Agreement shall state the Exercise Price, which, in the case of an Incentive Stock Option, shall not be less than one hundred percent (100%) of the Fair
Market Value of the Shares covered by the Option on the date of grant or such other amount as may be required pursuant to the Code. In the case of a Nonqualified Stock Option granted to any Grantee other than a Ten-Percent Shareholder, the per Share
exercise price shall be no less than 85% of the Fair Market Value of the Shares covered by the Option on the date of grant. In the case of an Incentive Stock Option (and also with respect to any grant of a Nonqualified Stock Option when intended to
be exempt from qualification pursuant to California Corporations Code Sec. 25102(o)) granted to any Ten-Percent Shareholder, the Exercise Price shall be no less than 110% of the Fair Market Value of the Shares covered by the Option on the date of
grant. In no event shall the Exercise Price of an Option be less than the nominal value of the shares for which such Option is exercisable. The Exercise Price shall also be subject to adjustment as provided in Section 13 hereof.

  

	 	6.4.	MANNER OF EXERCISE. An Option may be exercised, as to any or all whole Shares as to which the Option has become exercisable (but not less than 100 Shares unless the exercise is for
all vested Options held by such Grantee), by written notice delivered in person or by mail to the Secretary of the Company, specifying the number of Shares with respect to which the Option is being exercised, along with payment of the Exercise Price
for such Shares in the manner specified in the following sentence. The Exercise Price shall be paid in full with respect to each Share, at the time of exercise, in cash or cash equivalents, or in such other manner as the Committee shall determine.

  

	 	6.5.	 TERM AND VESTING OF OPTIONS. Each Option Agreement shall provide the vesting schedule for the Option as determined by the Committee, 

  

 - 5 - 

	 	 
provided that the Committee shall have the authority to accelerate the vesting of any outstanding Option at such time and under such circumstances as it, in
its sole discretion, deems appropriate. Unless otherwise stated in the Option Agreement, Options shall vest and become exercisable under the following schedule: one-forty-eighth (1/48) of the Option Shares shall vest at the end of each month of
continuous employment with the Company or one of its subsidiaries (“Employment”) subsequent to the effective date of Option Grant, provided, however, that any Option Shares that would otherwise vest during the Grantee’s first twelve
months of Employment shall vest, instead, upon the completion of the first twelve months of Employment; provided, however, that the Committee, in its absolute discretion, may, on such terms and conditions as it may determine to be appropriate,
accelerate or otherwise change the time at which such Option or any portion thereof may be exercised; provided further that, in the case of a Grantee who is not an officer, director, manager or consultant of the Company or a Subsidiary, the vesting
shall in no event be less favorable to the Grantee than 20% per year over a period of five years from the date of grant. The Option Agreement may contain performance goals and measurements, and the provisions with respect to any Option need not be
the same as the provisions with respect to any other Option. The Exercise Period of an Option will be ten (10) years from the date of the Grant of the Option unless otherwise shortened by the Committee. The Exercise Period shall be subject to
earlier termination as provided in Sections 6.6 and 6.7 hereof. 

  

	 	6.6.	 TERMINATION. Except as provided in this Section 6.6 and in Section 6.7 hereof, an Option may not be exercised unless the Grantee is then in the employ of or
maintaining a director or consultant relationship with the Company or a Subsidiary thereof or, in the case of an Incentive Stock Option, a company or a parent or subsidiary company of such company issuing or assuming the Option in a transaction to
which Section 424(a) of the Code applies, and unless the Grantee has remained continuously so employed or in the director or consultant relationship since the date of grant of the Option. In the event that the employment or director or consultant
relationship of a Grantee shall terminate (other than by reason of death, Disability or Retirement), all Options of such Grantee that are vested and exercisable at the time of such termination may, unless earlier terminated in accordance with their
terms, be exercised within ninety (90) days after the date of such termination (or such different period as the Committee shall prescribe, but in no event less than thirty (30) days, unless termination is for cause (as defined below), in the case of
an Option granted to a non-officer employee that is intended to be exempt from qualification pursuant to California Corporations Code Sec. 25102(o)); provided, however, that if the Company or Subsidiary shall terminate the Grantee’s employment
for cause (as defined below) (as determined by the Committee), all Options theretofore granted to such Grantee (whether vested or not) shall, to the extent not theretofore exercised, terminate on the date of such termination or cessation unless
otherwise determined by the Committee. In the case of a Grantee whose principal employer is a Subsidiary, the Grantee’s employment shall be deemed terminated for purposes of this Section 6.6 as of the date on which such 

  

 - 6 - 

	 	 
principal employer ceases to be a Subsidiary. Notwithstanding anything to the contrary, the Committee, in its absolute discretion may, on such terms and
conditions as it may determine appropriate, extend the periods for which the Options held by any individual may continue to vest and be exercisable; provided, that such Options may lose their status as Incentive Stock Options under applicable law
and be deemed Nonqualified Stock Options in the event that the period of vesting and/or exercisability of any option is extended beyond the later of: (i) ninety (90) days after the date of cessation of employment or performance of services; or (ii)
the applicable period under Section 6.7 below. 

  
 For purposes of this Plan, the term “cause” shall mean any of the following resulting from an act or omission of Grantee: (a) fraud, embezzlement or felony or similar act; (b) failure to substantially perform duties as an employee
or to abide by the general policies of the Company (or the Subsidiary employing the Grantee, as the case may be) applicable to all employees (including, without limitation, policies relating to confidentiality and reasonable workplace conduct); (c)
an act of moral turpitude, or any similar act, to the extent that such act causes injury to the reputation of the Company; (d) any other act or omission which in the reasonable opinion of the Company could be financially injurious to the Company or
a Subsidiary or injurious to the business reputation of the Company or a Subsidiary; or (e) any other acts or omissions constituting grounds for termination for cause under the Grantee’s employment or consulting agreement with the Company or a
Subsidiary, to the extent applicable. 
  

	 	6.7.	 DEATH, DISABILITY OR RETIREMENT OF GRANTEE. If a Grantee shall die while employed by, or maintaining a director or consultant relationship with, the Company or a
Subsidiary, or within ninety (90) days after the date of termination of such Grantee’s employment or director or consultant relationship (or within such different period as the Committee may have provided pursuant to Section 6.6 hereof), or if
the Grantee’s employment or director or consultant relationship shall terminate by reason of Disability, all Options theretofore granted to such Grantee (to the extent otherwise vested and exercisable) may, unless earlier terminated in
accordance with their terms, be exercised by the Grantee or by the Grantee’s estate or by a person who acquired the right to exercise such Options by bequest or inheritance or otherwise by result of death or Disability of the Grantee, at any
time within one (1) year after the death or Disability of the Grantee (or such different period as the Committee shall prescribe, but in no event less than six (6) months, in the case of an Option granted to a non-officer employee that is intended
to be exempt from qualification pursuant to California Corporations Code Sec. 25102(o)). In the event that an Option granted hereunder shall be exercised by the legal representatives of a deceased or former Grantee, written notice of such exercise
shall be accompanied by a certified copy of letters testamentary or equivalent proof of the right of such legal representative to exercise such Option. In the event that the employment or director or consultant relationship of a Grantee shall
terminate on account of such Grantee’s Retirement, all Options of such Grantee that are exercisable at the time of such Retirement may, unless 

  

 - 7 - 

	 	 
earlier terminated in accordance with their terms, be exercised at any time within one hundred eighty (180) days after the date of such Retirement (or such
different period as the Committee shall prescribe). 

  

	 	6.8.	LOANS. To the extent permitted under law, the Company or a Subsidiary may make loans to Grantees as the Committee, in its discretion, may determine in connection with the exercise
of outstanding Options granted under the Plan. Such loans shall: (i) be evidenced by promissory notes entered into by the Grantees in favor of the Company or Subsidiary, as the case may be; (ii) be subject to the terms and conditions set forth in
this Section 6.8 and such other terms and conditions, not inconsistent with the Plan, as the Committee shall determine; and (iii) bear interest, if any, at such rate as the Committee shall determine. In no event may the principal amount of any such
loan exceed the aggregate Exercise Price less the nominal value of the Shares covered by the Option, or portion thereof, exercised by the Grantee. The initial term of the loan, the schedule of payments of principal and interest under the loan, the
extent to which the loan is to be with or without recourse against the Grantee with respect to principal and/or interest and the conditions upon which the loan will become payable in the event of the Grantee’s termination of employment or
ceasing to perform services shall be determined by the Committee; provided, however, that the term of the loan including extensions, shall not exceed 10 years. Unless the Committee determines otherwise, when a loan shall have been made, Shares
having a Fair Market Value at least equal to the principal amount of the loan shall be pledged by the Grantee to the Company, the relevant Subsidiary or to a trustee appointed by the Company as security for payment of the unpaid balance of the loan
and such pledge shall be evidenced by a pledge agreement, the terms of which shall be determined by the Committee, in its discretion; provided, however, that each loan shall comply with all applicable laws. 

  

	 	6.9.	ATTENDANCE AND VOTING BY TRUSTEE. So long as any such Shares are held by a Trustee and unless the Trustee shall be directed otherwise by the Board, the Trustee shall (i) attend and
be present at all meetings of the shareholders of the Company of which it receives notice and be counted towards a quorum; and (ii) abstain from voting such Shares at all such meetings. 

  

	 	6.10.	OTHER PROVISIONS. The Option Agreements evidencing Awards under the Plan shall contain such other terms and conditions not inconsistent with the Plan as the Committee may determine.

  

	7.	102 STOCK OPTIONS. 

  
 Options granted pursuant to this Section 7 are intended to constitute 102 Stock Options and subject to Section 102 of the Ordinance and the rules and
regulations promulgated thereunder, as amended, the general terms and conditions specified in Section 6 hereof and other provisions of the Plan, except for said provisions of the Plan applying to Options under a different tax law or regulation,
shall apply. 
  
 To the extent required by the Ordinance or the
Income Tax Commissioner of the State of Israel or otherwise deemed prudent or desirable by the Committee, the 102 Stock 

  

 - 8 - 

 
Options which shall be granted pursuant to the Plan shall be issued to a Trustee nominated by the Committee in accordance with the provisions of the
Ordinance and the Options and Shares issued upon the exercise of said Option shall be held for the benefit of the Grantee for the period from the date of grant as is required by the Ordinance). 
  

	8.	3(9) STOCK OPTIONS. 

  
 Options granted pursuant to this Section 8 are intended to constitute 3(9) Stock Options and shall be subject to the general terms and conditions
specified in Section 6 hereof and other provisions of the Plan, except for said provisions of the Plan applying to Options under a different tax law or regulation. 
  
 To the extent required by the Ordinance or the Income Tax Commissioner of the State of Israel or otherwise deemed prudent or
desirable by the Committee, the 3(9) Stock Options which shall be granted pursuant to the Plan shall be issued to a Trustee. 
  

	9.	NONQUALIFIED STOCK OPTIONS. 

  
 Options granted pursuant to this Section 9 are intended to constitute Nonqualified Stock Options and shall be subject to the general terms and conditions
specified in Section 6 hereof and other provisions of the Plan, except for said provisions of the Plan applying to Options under a different tax law or regulation. 
  

	10.	INCENTIVE STOCK OPTIONS. 

  
 Options granted pursuant to this Section 10 are intended to constitute Incentive Stock Options and shall be subject to both the following special terms
and conditions and the general terms and conditions specified in Section 6 hereof and other provisions of the Plan, except for said provisions of the Plan applying to Options under a different tax law or regulation: 
  

	 	10.1. 	VALUE OF SHARES. The aggregate Fair Market Value (determined as of the date the Incentive Stock Option is granted) of the Shares with respect to which Incentive Stock Options
granted under this Plan and all other option plans of any Subsidiary become exercisable for the first time by each Grantee during any calendar year shall not exceed $100,000 with respect to such Grantee. To the extent that the aggregate Fair Market
Value of Shares with respect to which the Incentive Stock Options are exercisable for the first time by any Grantee during any calendar years exceeds $100,000, such Options shall be treated as Non-Qualified Stock Options. The foregoing shall be
applied by taking options into account in the order in which they were granted, with the Fair Market Value of any Share to be determined at the time of the grant of the Option. In the event the foregoing results in the portion of an Incentive Stock
Option exceeding the $100,000 limitation, only such excess shall be treated as a Non-Qualified Stock Option. 

  

	 	10.2. 	TEN PERCENT SHAREHOLDER. In the case of an Incentive Stock Option granted to a Ten Percent Shareholder, (i) the Exercise Price shall not be less than one hundred ten percent (110%)
of the Fair Market Value of the Shares on the date of grant of such Incentive Stock Option, and (ii) the Exercise Period shall not exceed five (5) years from the date of grant of such Incentive Stock Option. 

  

 - 9 - 

	11.	RESTRICTED STOCK. 

  
 The Committee may award shares of Restricted Stock to any eligible employee, director or consultant, including under Section 102 of the Ordinance. Each
Award of Restricted Stock under the Plan shall be evidenced by a written agreement between the Company and the Grantee (the “Restricted Stock Agreement”), in such form as the Committee shall from time to time approve, which Restricted
Stock Agreement shall comply with and be subject to the following terms and conditions, unless otherwise specifically provided in such Agreement: 
  

	 	11.1. 	NUMBER OF SHARES. Each Restricted Stock Agreement shall state the number of shares of Restricted Stock to be subject to an Award. 

  

	 	11.2. 	RESTRICTIONS. Shares of Restricted Stock may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and
distribution, for such period as the Committee shall determine from the date on which the Award is granted (the “Restricted Period”). The Committee may also impose such additional or alternative restrictions and conditions on the Shares of
Restricted Stock as it deems appropriate including the satisfaction of performance criteria. Such performance criteria may include sales, earnings before interest and taxes, return on investment, earnings per share, any combination of the foregoing
or rate of growth of any of the foregoing, as determined by the Committee. Certificates for Shares issued pursuant to Restricted Stock Awards shall bear an appropriate legend referring to such restrictions, and any attempt to dispose of any such
Shares in contravention of such restrictions shall be null and void and without effect. During the Restricted Period, such certificates shall be held in escrow by an escrow agent appointed by the Committee, or, if a Restricted Stock Award is made
pursuant to Section 102, by the Trustee. In determining the Restricted Period of an Award the Committee may provide that the foregoing restrictions shall lapse with respect to specified percentages of the awarded shares monthly or on any other
periodic basis that the Committee may decide. To the extent required by the Ordinance or the Income Tax Commissioner of the State of Israel, the Restricted Stock issued pursuant to Section 102 of the Ordinance shall be issued to a trustee nominated
by the Board or the Committee in accordance with the provisions of the Ordinance (the “Trustee”) and the Restricted Stock shall be held for the benefit of the Grantee for a period of not less than twenty-four (24) months from the date of
grant (or such other period of time as may be required by the Ordinance). 

  

	 	11.3. 	ADJUSTMENT OF PERFORMANCE GOALS. The Committee may adjust performance goals to take into account changes in law and accounting and tax rules and to make such adjustments as the
Committee deems necessary or appropriate to reflect the inclusion or the exclusion of the impact of extraordinary or unusual items, events or circumstances. The Committee also may adjust the performance goals by reducing the amount to be received by
any Grantee pursuant to an Award if and to the extent that the Committee deems it appropriate. 

  

	 	11.4. 	 FORFEITURE. Subject to such exceptions as may be determined by the Committee, if the Grantee’s continuous employment or director or consultant 

  

 - 10 - 

	 	 
relationship with the Company or any Subsidiary shall terminate for any reason prior to the expiration of the Restricted Period of an Award, any Shares
remaining subject to restrictions (after taking into account the provisions of Section 11.6) shall thereupon be forfeited by the Grantee and transferred to, and reacquired by, the Company or a Subsidiary at no cost to the Company or Subsidiary,
subject to all applicable law. 

  

	 	11.5. 	OWNERSHIP. During the Restricted Period the Grantee shall possess all incidents of ownership of such shares, subject to Section 11.2, including the right to receive dividends with
respect to such Shares and to vote such Shares. 

  

	 	11.6. 	ACCELERATED LAPSE OF RESTRICTIONS. Upon the occurrence of any of the events listed in Sections 13.2 and subject to Section 13.3, all restrictions then outstanding with respect to
shares of Restricted Stock awarded hereunder shall automatically expire and be of no further force and effect. The Committee shall have the authority (and the Agreement may so provide) to cancel all or any portion of any outstanding restrictions
prior to the expiration of the Restricted Period with respect to any or all of the Shares of Restricted Stock awarded on such terms and conditions as the Committee shall deem appropriate. 

  

	12.	OTHER SHARE-BASED AWARDS. 

  
 The Committee may grant other Awards under the Plan pursuant to which Shares (which may, but need not, be shares of Restricted Stock pursuant to Section
11 hereof) are or may in the future be acquired, or Awards denominated in stock units, including units valued on the basis of measures other than market value. The Committee may also grant stock appreciation rights without the grant of an
accompanying option, which rights shall permit the Grantees to receive, at the time of any exercise of such rights, cash equal to the amount by which the Fair Market Value of all Shares in respect to which the right was granted exceeds the exercise
price thereof. Such other stock based Awards may be granted alone, in addition to, or in tandem with any Award of any type granted under the plan and must be consistent with the purposes of the Plan. 
  

	13.	EFFECT OF CERTAIN CHANGES. 

  

	 	13.1. 	General. In the event of a subdivision of the outstanding share capital of the Company, any payment of a stock dividend (distribution of bonus shares), a recapitalization, a
reorganization (which may include a combination or exchange of shares), a consolidation, a stock split, a spin-off or other corporate divestiture or division, a reclassification or other similar occurrence, the Committee shall make appropriate
adjustments in one or more of (i) the number of Shares available for Awards; (ii) the number of such Shares covered by outstanding Awards; and (iii) the exercise price per share covered by the Option Awards; provided, however, that any fractional
shares resulting from such adjustment shall be rounded down to the nearest whole share. 

  

	 	13.2. 	 Merger and Sale of Company. In the event of (i) a sale of all or substantially all of the assets of the Company; or (ii) a sale (including an exchange) of all of
the shares of capital stock of the Company; or (iii) the merger, 

  

 - 11 - 

	 	 
consolidation, amalgamation or like transaction of the Company with or into another corporation; or (iv) scheme of arrangement for the purpose of effecting
such sale, merger or amalgamation (all such transactions being herein referred to as a “Merger/Sale”), then, without the Grantee’s consent and action - 

  

	 	13.2.1. 	the Committee in its sole discretion will use its efforts to cause that any Award then outstanding be assumed or an equivalent Award shall be substituted by such successor
corporation or, in such event that such transaction is effected through a subsidiary, the Parent of such successor corporation, under substantially the same terms as the Award; and 

  

	 	13.2.2. 	in such case that such successor corporation or other entity does not agree to assume the Award or to substitute an equivalent Award and, if the Award is an Option (“Option
Award”), then the Committee shall, in lieu of such assumption or substitution of the Option Award and in its sole discretion, either (i) provide for the Grantee to have the right to exercise the Option Award as to all of the Shares or any part
thereof, including Shares covered by the Option Award which would not otherwise be exercisable, under such terms and conditions as the Committee shall determine or (ii) provide for the cancellation of each outstanding Option Award at the closing of
said Merger/Sale, against payment to the Grantee of an amount in cash equal to (a) the fair market value of each Share covered by the Option Award as reflected under the terms of the Merger/Sale, minus (b) the Exercise Price of each Share covered by
the Option Award. 

  

	 	13.2.3. 	Notwithstanding the foregoing, in the event of a Merger/Sale, the Committee may determine in its sole discretion that upon completion of such Merger/Sale, the terms of any Award be
otherwise amended and modified, as the Committee shall deem in good faith to be appropriate, and if an Option Award, that the Option Award shall confer the right to purchase any other security or asset, or any combination thereof, or that its terms
be otherwise amended or modified, as the Committee shall deem in good faith to be appropriate. 

  

	 	13.3. 	 Reservation of Rights. Except as expressly provided in this Section 13, the Grantee of an Award hereunder shall have no rights by reason of any subdivision or
consolidation of stock of any class or the payment of any stock dividend (bonus shares) or any other increase or decrease in the number of Shares of stock of any class or by reason of any dissolution, liquidation, Merger/Sale, or consolidation,
divestiture or spin-off of assets or stock of another company; and any issue by the Company of stock of any class, or securities convertible into shares of stock of any class, shall not effect, and no adjustment by reason thereof shall be made with
respect to, the number or price of Shares subject to an Award. The grant of an Award pursuant to the Plan shall not affect in any way the right of power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital
or 

  

 - 12 - 

	 	 
business structures or to merge or to consolidate or to dissolve, liquidate or sell, or transfer all or part of its business or assets or engage in any
similar transactions. 

  

	14.	NON-TRANSFERABILITY OF AWARDS; SURVIVING BENEFICIARY. 

  
 Until the Initial Public Offering, all Awards granted under the Plan shall not be transferable otherwise than by will or by the laws of descent and
distribution, and Awards may be exercised or otherwise realized, during the lifetime of the Grantee, only by the Grantee or by his guardian, or legal representative, to the extent provided for herein. A Grantee may file with the Committee a written
designation of a beneficiary on such form as may be prescribed by the Committee and may, from time to time, amend or revoke such designation. If no designated beneficiary survives the Grantee, the executor or administrator of the Grantee’s
estate shall be deemed to be the Grantee’s beneficiary. 
  

	15.	AGREEMENT BY GRANTEE REGARDING TAXES. 

  
 If the Committee shall so require, as a condition of exercise of an Option, the release of Shares by the Trustee or the expiration of the Restricted
Period (each a “Tax Event”), each Grantee shall agree that, no later than the date of the Tax Event, he will pay to the Company or make arrangements satisfactory to the Committee and the Trustee (if applicable) regarding payment of any
applicable taxes of any kind required by law to be withheld or paid upon the Tax Event. 
  
 All tax consequences under any applicable law which may arise from the grant of any options, restricted stock or shares, or in the case of an Option, from its exercise, from the sale or disposition of the Shares or
Restricted Stock or from any other act of the Grantee in connection with the foregoing shall be borne solely by the Grantee, and the Grantee shall indemnify the Company, and the Trustee, and shall hold them harmless against and from any liability
for any such tax or penalty, interest or indexation thereon or thereupon. 
  

	16.	RIGHTS AS A SHAREHOLDER; VOTING AND DIVIDENDS. 

  
 A Grantee or a transferee of an Award shall have no rights as a shareholder with respect to any Shares covered by the Award until the date of the issuance
of a Share certificate to him for such Shares, or, in the case of 102 Stock Options or 3(9) Stock Options (if such 3(9) Stock Options are being held by a Trustee), until the date of the issuance of a Share certificate to the Trustee. No adjustment
shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distribution of other rights for which the record date is prior to the date such Share Certificate is issued, except as provided in Section
13.1 hereof. In the event that a Trustee holds Shares issued upon the exercise of 102 Stock Options, any cash dividends paid by the Company on such Shares shall be paid directly to the Grantee and any stock dividends (bonus shares) shall be paid to
the Trustee. Each Grantee will receive financial statements of the Company at least annually. 
  

	17.	NO RIGHTS TO EMPLOYMENT. 

  
 Nothing in the Plan or in any Award granted or Agreement entered into pursuant hereto shall confer upon any Grantee the right to continue in the employ
of, or in a consultant relationship with, the Company or any Subsidiary or to be entitled to any remuneration or benefits not set forth in the Plan or such Agreement or to interfere 

  

 - 13 - 

 
with or limit in any way the right of the Company or any such Subsidiary to terminate such Grantee’s employment. Awards granted under the Plan shall not
be affected by any change in duties or position of a Grantee as long as such Grantee continues to be employed by, or in a consultant or director relationship with, the Company or any Subsidiary. 
  

	18.	APPROVAL. 

  
 The Plan shall take effect upon its adoption by the Board and shall terminate on the tenth anniversary of such date. Notwithstanding the foregoing, in the event that approval of the Plan by the shareholders of the
Company is required under applicable law, in connection with the application of certain tax treatment or pursuant to applicable stock exchange rules or regulations or otherwise, such approval shall be obtained within the time required under the
applicable law. 
  

	19.	PERIOD DURING WHICH AWARDS MAY BE GRANTED. 

  
 Awards may be granted pursuant to the Plan from time to time within a period of ten (10) years from the date the Plan is adopted by the Board. 

 

	20.	AMENDMENT AND TERMINATION OF THE PLAN. 

  
 The Board at any time and from time to time may suspend, terminate, modify or amend the Plan; provided, however, that, unless otherwise determined by the
Board, an amendment which requires shareholder approval in order for the Plan to continue to comply with any law, regulation or stock exchange requirement shall not be effective unless approved by the requisite vote of stockholders. Except as
provided in Section 13.1 hereof, no suspension, termination, modification or amendment of the Plan may adversely affect any Award previously granted, unless the written consent of the Grantee is obtained. 
  

	21.	GOVERNING LAW. 

  
 The Plan and all determinations made and actions taken pursuant hereto shall be governed by the laws of the State of Israel. 
  

 - 14 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]